E-LIB Suche - Ergebnisse für: MANNS, M

1

Prevalence of resistance-associated substitutions and retre..:

de Salazar, Adolfo ; Dietz, Julia ; di Maio, Velia Chiara...
Journal of Antimicrobial Chemotherapy. 75 (2020) 11 - p. 3349-3358 , 2020

Link: https://doi.org/10.1093/..

2

Examinations on the Grain Size/Scattered Light Value Relati..:

Geisler, T. ; Manns, M.
Practical Metallography. 56 (2019) 3 - p. 171-187 , 2019

Link: https://doi.org/10.3139/..

3

Transitionsmedizin:

Siegmund, B. ; Lehnert, H. ; Manns, M.
Der Internist. 59 (2018) 11 - p. 1125-1127 , 2018

Link: https://doi.org/10.1007/..

4

A168 USE OF LEDIPASVIR/SOFOSBUVIR (LDV/SOF) WITH OR WITHOUT..:

Bourliere, M ; Charlton, M ; Manns, M...
Journal of the Canadian Association of Gastroenterology. 1 (2018) suppl_1 - p. 291-292 , 2018

Link: https://doi.org/10.1093/..

5

The road map toward an hepatitis C virus-free transplant po..:

Berenguer, M. ; Agarwal, K. ; Burra, P...
American Journal of Transplantation. 18 (2018) 10 - p. 2409-2416 , 2018

Link: https://doi.org/10.1111/..

6

Identification of a highly cross-reactive CD8+ T cell reper..:

Soon, C.F. ; Markova, A. ; Wedemeyer, H.H....
Journal of Hepatology. 66 (2017) 1 - p. S327 , 2017

Link: https://doi.org/10.1016/..

7

Common variation near glial-derived neurotrophic factor is ..:

Shea, P. ; Hirschfield, G. ; Shiffman, M....
Journal of Hepatology. 66 (2017) 1 - p. S4-S5 , 2017

Link: https://doi.org/10.1016/..

8

The safety and tolerability of SOF/VEL/VOX for 8 or 12 week..:

Manns, M. ; Gane, E.J. ; Willems, B.E....
Journal of Hepatology. 66 (2017) 1 - p. S722-S723 , 2017

Link: https://doi.org/10.1016/..

9

Prospective validation of serum alkaline phosphatase for th..:

Levy, C. ; Eksteen, B. ; Shiffman, M....
Journal of Hepatology. 66 (2017) 1 - p. S360-S361 , 2017

Link: https://doi.org/10.1016/..

10

Viral Dominance patterns in hepatitis delta patients are as..:

Lutterkort, G.L. ; Anika, W. ; Hengst, J....
Journal of Hepatology. 66 (2017) 1 - p. S486 , 2017

Link: https://doi.org/10.1016/..

11

SOF/VEL/VOX results in high SVR12 rates when administered f..:

Roberts, S.K. ; Cooper, C.L. ; Lawitz, E....
Journal of Hepatology. 66 (2017) 1 - p. S741 , 2017

Link: https://doi.org/10.1016/..

12

A combined bile and urine proteomic test for cholangiocarci..:

Voigtländer, T. ; Metzger, J. ; Jäger, M...
Journal of Hepatology. 66 (2017) 1 - p. S625 , 2017

Link: https://doi.org/10.1016/..

13

A novel mid-scale screening assay to identify compounds wit..:

Buchmann, B. ; Döhner, K. ; Schirdewahn, T....
Journal of Hepatology. 66 (2017) 1 - p. S258 , 2017

Link: https://doi.org/10.1016/..

14

Efficacy and safety of simtuzumab for the treatment of prim..:

Muir, A. ; Goodman, Z. ; Levy, C....
Journal of Hepatology. 66 (2017) 1 - p. S73 , 2017

Link: https://doi.org/10.1016/..

15

Ledipasvir/Sofosbuvir for 12 or 24 Weeks Is Safe and Effect..:

Colombo, M. ; Aghemo, A. ; Liu, L....
Journal of Hepatology. 64 (2016) 2 - p. S183 , 2016

Link: https://doi.org/10.1016/..